Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bacille calmette-guerin (1 trial)
bleomycin (blenoxane) (1 trial)
cisplatin (platinol) (2 trials)
darolutamide (Nubeqa) (1 trial)
enzalutamide (xtandi) (4 trials)
etoposide (vepesid) (1 trial)
Filgrastim (neupogen) (1 trial)
methoxyflurane (penthrane) (1 trial)
mitomycin (mutamycin) (1 trial)
sargramostim (leukine) (1 trial)
177lu-psma-r2 (1 trial)
abiraterone (zytiga) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
cabozantinib (cometriq) (1 trial)
denosumab (prolia) (1 trial)
docetaxel (taxotere) (2 trials)
ipilimumab (yervoy) (2 trials)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (3 trials)
nivolumab (opdivo) (2 trials)
paclitaxel (taxol) (1 trial)
pembrolizumab (keytruda) (2 trials)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Kidney Neoplasms (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Prostatic Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (17 total)
Trial APIs (21 total)